Search research articles
Contact Us
Filters
Showing results (31-40 of 80) with videos related to
Page
of 8
Sort By:
European Journal of Ophthalmology
|
July 21, 2020
Corneal collagen cross-linking for management of keratoconus in patients affected by Tourette syndrome
Karl Anders Knutsson, Giorgio Paganoni, Oriella Ambrosio, et al.
Experimental Eye Research
|
April 24, 2016
Corrigendum to "Corneal innervation as a window to peripheral neuropathies" [Exp. Eye Res. 113 (2013) 148-150]
Giulio Ferrari, Nambi Nallasamy, Heather Downs, et al.
Investigative Ophthalmology & Visual Science
|
April 7, 2018
Substance P Modulation of Human and Murine Corneal Neovascularization
Marco Barbariga, Phillippe Fonteyne, Manoosh Ostadreza, et al.
Investigative Ophthalmology & Visual Science
|
October 26, 2021
A Hypothalamic-Controlled Neural Reflex Promotes Corneal Inflammation
Romina Mayra Lasagni Vitar, Philippe Fonteyne, Linda Chaabane, et al.
The Ocular Surface
|
April 10, 2012
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)
William Stevenson, Sheng-Fu Cheng, Mohammad H Dastjerdi, et al.
The Ocular Surface
|
January 29, 2024
Corrigendum to "Topical formulations of aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration" [Ocul Surf 30 (2023) 92-103]
Filippo Bonelli, Ibrahim Demirsoy, Romina Mayra Lasagni Vitar, et al.
Investigative Ophthalmology & Visual Science
|
September 18, 2014
NK1 receptor antagonists as a new treatment for corneal neovascularization
Fabio Bignami, Chiara Giacomini, Anna Lorusso, et al.
The Ocular Surface
|
September 10, 2023
Topical formulations of Aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration
Filippo Bonelli, Ibrahim Demirsoy, Romina Mayra Lasagni Vitar, et al.
American Journal of Ophthalmology Case Reports
|
December 11, 2023
Topical fosaprepitant for the treatment of ocular pain and inflammation
Giuseppe Suanno, Matteo Pederzolli, Romina Mayra Lasagni Vitar, et al.
Stem Cell Reports
|
March 25, 2022
Substance P/neurokinin-1 receptor pathway blockade ameliorates limbal stem cell deficiency by modulating mTOR pathway and preventing cell senescence
Romina Lasagni Vitar, Francesca Triani, Marco Barbariga, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 80) with videos related to
Sort By:
Page
of 8
European Journal of Ophthalmology
|
July 21, 2020
Corneal collagen cross-linking for management of keratoconus in patients affected by Tourette syndrome
Karl Anders Knutsson, Giorgio Paganoni, Oriella Ambrosio, et al.
Experimental Eye Research
|
April 24, 2016
Corrigendum to "Corneal innervation as a window to peripheral neuropathies" [Exp. Eye Res. 113 (2013) 148-150]
Giulio Ferrari, Nambi Nallasamy, Heather Downs, et al.
Investigative Ophthalmology & Visual Science
|
April 7, 2018
Substance P Modulation of Human and Murine Corneal Neovascularization
Marco Barbariga, Phillippe Fonteyne, Manoosh Ostadreza, et al.
Investigative Ophthalmology & Visual Science
|
October 26, 2021
A Hypothalamic-Controlled Neural Reflex Promotes Corneal Inflammation
Romina Mayra Lasagni Vitar, Philippe Fonteyne, Linda Chaabane, et al.
The Ocular Surface
|
April 10, 2012
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)
William Stevenson, Sheng-Fu Cheng, Mohammad H Dastjerdi, et al.
The Ocular Surface
|
January 29, 2024
Corrigendum to "Topical formulations of aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration" [Ocul Surf 30 (2023) 92-103]
Filippo Bonelli, Ibrahim Demirsoy, Romina Mayra Lasagni Vitar, et al.
Investigative Ophthalmology & Visual Science
|
September 18, 2014
NK1 receptor antagonists as a new treatment for corneal neovascularization
Fabio Bignami, Chiara Giacomini, Anna Lorusso, et al.
The Ocular Surface
|
September 10, 2023
Topical formulations of Aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration
Filippo Bonelli, Ibrahim Demirsoy, Romina Mayra Lasagni Vitar, et al.
American Journal of Ophthalmology Case Reports
|
December 11, 2023
Topical fosaprepitant for the treatment of ocular pain and inflammation
Giuseppe Suanno, Matteo Pederzolli, Romina Mayra Lasagni Vitar, et al.
Stem Cell Reports
|
March 25, 2022
Substance P/neurokinin-1 receptor pathway blockade ameliorates limbal stem cell deficiency by modulating mTOR pathway and preventing cell senescence
Romina Lasagni Vitar, Francesca Triani, Marco Barbariga, et al.
Page
of 8